{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:54:20Z","timestamp":1790124860264,"version":"4.0.1"},"reference-count":124,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma (HCC) is a highly lethal malignancy with rising global incidence. Aberrantly activated aerobic glycolysis is a hallmark of HCC, driving excessive lactate production and the formation of an acidic tumor microenvironment (TME) that promotes malignant progression. Elucidating the underlying mechanisms of this metabolic axis is essential for developing targeted therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This review systematically examines the role of the aerobic glycolysis-lactate-acidic TME axis in HCC progression, focusing on its molecular basis, multifaceted functions of lactate, and therapeutic implications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Findings<\/jats:title>\n                    <jats:p>HCC progression is driven by a coordinated \u201cproduction-efflux\u201d mechanism involving glycolytic rate-limiting enzymes (such as HK2, PKM2, LDH) and the lactate transporter such as MCT4, which together facilitate lactate accumulation and TME acidification. Lactate exerts pleiotropic effects within the TME, including metabolic signaling via GPR81 and ASICs, epigenetic regulation through histone lactylation, and inter-organ crosstalk via the gut\u2013liver axis. Current therapeutic strategies targeting GLUTs, glycolytic enzymes, LDH, and MCT4 are reviewed, along with approaches for direct TME alkalinization and combination regimens with targeted agents. Building upon this landscape, the present review is the first to systematically integrate emerging mechanisms such as histone lactylation and the gut-liver axis, and to explore the synergistic potential of combining metabolic inhibitors with immunotherapy, thereby offering a distinct framework that moves beyond traditional glycolysis-centric narratives in HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Challenges and Perspectives<\/jats:title>\n                    <jats:p>Despite the substantial potential of targeting this metabolic axis, a considerable gap remains between preclinical findings and clinical translation. The pronounced heterogeneity of HCC, along with metabolic plasticity and insufficient drug selectivity, poses major challenges. Future efforts should prioritize the development of highly selective inhibitors and the optimization of combination therapies based on metabolic stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1704729","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:42:38Z","timestamp":1778215358000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Aerobic glycolysis-driven lactate accumulation and acidic tumor microenvironment in hepatocellular carcinoma: a vicious cycle promoting tumor progression"],"prefix":"10.3389","volume":"17","author":[{"given":"Mengzhuo","family":"Liu","sequence":"first","affiliation":[{"name":"Shaanxi University of Chinese Medicine","place":["Xianyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhe","family":"Jiao","sequence":"additional","affiliation":[{"name":"Shaanxi University of Chinese Medicine","place":["Xianyang, China"]},{"name":"Departments of Infectious Disease, The Affiliated Hospital of Shaanxi University of Chinese Medicine","place":["Xianyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Basic Medicine, Shaanxi University of Chinese Medicine","place":["Xianyang, China"]},{"name":"Department of Pathology, Shaanxi University of Chinese Medicine","place":["Xianyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanjie","family":"Chang","sequence":"additional","affiliation":[{"name":"Departments of Infectious Disease, The Affiliated Hospital of Shaanxi University of Chinese Medicine","place":["Xianyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[{"name":"Departments of Infectious Disease, The Affiliated Hospital of Shaanxi University of Chinese Medicine","place":["Xianyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Guan","sequence":"additional","affiliation":[{"name":"Shaanxi University of Chinese Medicine","place":["Xianyang, China"]},{"name":"Departments of Infectious Disease, The Affiliated Hospital of Shaanxi University of Chinese Medicine","place":["Xianyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijuan","family":"Yan","sequence":"additional","affiliation":[{"name":"Departments of Infectious Disease, The Affiliated Hospital of Shaanxi University of Chinese Medicine","place":["Xianyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Huang","sequence":"additional","affiliation":[{"name":"College of Basic Medicine, Shaanxi University of Chinese Medicine","place":["Xianyang, China"]},{"name":"Department of Warm Disease, Shaanxi University of Chinese Medicine","place":["Xianyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Xi","sequence":"additional","affiliation":[{"name":"Departments of Infectious Disease, The Affiliated Hospital of Shaanxi University of Chinese Medicine","place":["Xianyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiaoyang","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Bao","sequence":"additional","affiliation":[{"name":"The Hangzhou Xixi Hospital Affiliated to the Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuguang","family":"Yan","sequence":"additional","affiliation":[{"name":"College of Basic Medicine, Shaanxi University of Chinese Medicine","place":["Xianyang, China"]},{"name":"Key Laboratory of Gastrointestinal Diseases and Prescriptions in Shaanxi Province, Shaanxi University of Chinese Medicine","place":["Xianyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingtao","family":"Li","sequence":"additional","affiliation":[{"name":"Shaanxi University of Chinese Medicine","place":["Xianyang, China"]},{"name":"Departments of Infectious Disease, The Affiliated Hospital of Shaanxi University of Chinese Medicine","place":["Xianyang, China"]},{"name":"Key Laboratory of Gastrointestinal Diseases and Prescriptions in Shaanxi Province, Shaanxi University of Chinese Medicine","place":["Xianyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s40364-025-00844-5","article-title":"Molecular network of metabolic reprogramming and precision diagnosis and treatment of hepatocellular carcinoma","volume":"13","author":"An","year":"2025","journal-title":"Biomark. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e2400032","DOI":"10.1200\/OA-24-00032","article-title":"Molecular characterization and clinical outcomes of pancreatic neuroendocrine neoplasms harboring PAK4-NAMPT alterations","volume":"2","author":"Azar","year":"2025","journal-title":"JCO Oncol. Adv."},{"key":"B4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41419-021-03505-1","article-title":"The crosstalk between HIFs and mitochondrial dysfunctions in cancer development","volume":"12","author":"Bao","year":"2021","journal-title":"Cell Death Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12967-017-1258-9","article-title":"Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability","volume":"15","author":"Broecker-Preuss","year":"2017","journal-title":"J. Transl. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"107451","DOI":"10.1016\/j.pharmthera.2019.107451","article-title":"Lactate\/GPR81 signaling and proton motive force in cancer: role in angiogenesis, immune escape, nutrition, and warburg phenomenon","volume":"206","author":"Brown","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1038\/s41467-024-46504-4","article-title":"Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas","volume":"15","author":"Broz","year":"2024","journal-title":"Nat. Commun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.19538\/j.cjps.issn1005-2208.2024.04.01","article-title":"Guideline for diagnosis and treatment of hepatocellular carcinoma(2024 edition)","volume":"44","year":"2024","journal-title":"Chin. J. Pract. Surg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","article-title":"Lactate modulation of immune responses in inflammatory versus tumour microenvironments","volume":"21","author":"Certo","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1111\/jgh.15548","article-title":"TFB2M activates aerobic glycolysis in hepatocellular carcinoma cells through the NAD+\/SIRT3\/HIF-1\u03b1 signaling","volume":"36","author":"Chang","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e15691","DOI":"10.7554\/eLife.15691","article-title":"A nonrandomized cohort and a randomized study of local control of large hepatocarcinoma by targeting intratumoral lactic acidosis","volume":"5","author":"Chao","year":"2016","journal-title":"Elife"},{"key":"B12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-020-01172-y","article-title":"The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis","volume":"19","author":"Chen","year":"2020","journal-title":"Mol. Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1038\/onc.2011.137","article-title":"Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2","volume":"30","author":"Chen","year":"2011","journal-title":"Oncogene"},{"key":"B14","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s00535-013-0848-4","article-title":"BAY 11-7082, a nuclear factor-\u03baB inhibitor, induces apoptosis and S phase arrest in gastric cancer cells","volume":"49","author":"Chen","year":"2014","journal-title":"J. Gastroenterol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s13046-022-02531-x","article-title":"Aerobic glycolysis enhances HBx-initiated hepatocellular carcinogenesis via NF-\u03baBp65\/HK2 signalling","volume":"41","author":"Chen","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13046-024-03042-7","article-title":"Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication","volume":"43","author":"Chen","year":"","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"216837","DOI":"10.1016\/j.canlet.2024.216837","article-title":"The emerging role of lactate in tumor microenvironment and its clinical relevance","volume":"590","author":"Chen","year":"","journal-title":"Cancer Lett."},{"key":"B18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/path.4218","article-title":"Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?","volume":"230","author":"Choi","year":"2013","journal-title":"J. Pathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"17685","DOI":"10.1038\/s41598-025-01402-7","article-title":"The effect of 2-Deoxy-D-glucose on glycolytic metabolism in acute myeloblastic leukemic ML-1 cells","volume":"15","author":"Christensen","year":"2025","journal-title":"Sci. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e240331","DOI":"10.1530\/ERC-24-0331","article-title":"Predictive value of metabolic state on PanNET response to mTOR inhibitors","volume":"32","author":"Cros","year":"2025","journal-title":"Endocr. Relat. Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.13437\/j.cnki.jcr.2017.01.033","article-title":"Two methods with TAICE with conventional contrast research for the treatment of primary liver cancer","volume":"36","author":"Dalin","year":"2017","journal-title":"J. Clin. Radiology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1172\/JCI69741","article-title":"Targeting lactate metabolism for cancer therapeutics","volume":"123","author":"Doherty","year":"2013","journal-title":"J. Clin. Invest"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.7150\/ijbs.81498","article-title":"ACE2 negatively regulates the warburg effect and suppresses hepatocellular carcinoma progression via reducing ROS-HIF1\u03b1 activity","volume":"19","author":"Dong","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e105038","DOI":"10.1371\/journal.pone.0105038","article-title":"Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival","volume":"9","author":"Eilertsen","year":"2014","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/cac2.12414","article-title":"Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib","volume":"43","author":"Eun","year":"2023","journal-title":"Cancer Commun. (Lond)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12943-016-0562-y","article-title":"Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors","volume":"15","author":"Faes","year":"2016","journal-title":"Mol. Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1124\/pr.119.018762","article-title":"Monocarboxylate transporters (SLC16): function, regulation, and role in health and disease","volume":"72","author":"Felmlee","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1038\/onc.2017.188","article-title":"Tumor cell-derived lactate induces TAZ-Dependent upregulation of PD-L1 through GPR81 in human lung cancer cells","volume":"36","author":"Feng","year":"2017","journal-title":"Oncogene"},{"key":"B29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","article-title":"Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma","volume":"39","author":"Feng","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s13346-020-00713-8","article-title":"A novel strategy for glioblastoma treatment combining alpha-cyano-4-hydroxycinnamic acid with cetuximab using nanotechnology-based delivery systems","volume":"10","author":"Ferreira","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbcan.2017.04.002","article-title":"Linking tumor glycolysis and immune evasion in cancer: emerging concepts and therapeutic opportunities","volume":"1868","author":"Ganapathy-Kanniappan","year":"2017","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00432-014-1888-8","article-title":"Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration","volume":"141","author":"Gao","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.canlet.2019.04.009","article-title":"Glycochenodeoxycholate promotes hepatocellular carcinoma invasion and migration by AMPK\/mTOR dependent autophagy activation","volume":"454","author":"Gao","year":"2019","journal-title":"Cancer Lett."},{"key":"B34","doi-asserted-by":"publisher","first-page":"22240","DOI":"10.1021\/acsnano.3c01199","article-title":"Long noncoding RNA URB1-Antisense RNA 1 (AS1) suppresses Sorafenib-Induced ferroptosis in hepatocellular carcinoma by driving ferritin phase separation","volume":"17","author":"Gao","year":"2023","journal-title":"ACS Nano"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7285","DOI":"10.2174\/0929867326666181213092652","article-title":"Unlocking the potential of HK2 in cancer metabolism and therapeutics","volume":"26","author":"Garcia","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"B36","first-page":"69","article-title":"Transarterial infusion of bevacizumab combined with TACE for the treatment of TACE - refractory HCC: therapeutic analysis of 13 cases","volume":"24","author":"Geng - fei","year":"2015","journal-title":"J. Interventional Radiology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s11130-022-01037-3","article-title":"Crithmum maritimum improves sorafenib sensitivity by decreasing lactic acid fermentation and inducing a pro-hepatocyte marker profile in hepatocellular carcinoma","volume":"78","author":"Gnocchi","year":"2023","journal-title":"Plant Foods Hum. Nutr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0269432","DOI":"10.1371\/journal.pone.0269432","article-title":"Mitochondrial metabolic reprogramming by SIRT3 regulation ameliorates drug resistance in renal cell carcinoma","volume":"17","author":"Gu","year":"2022","journal-title":"PLoS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1208\/s12248-020-00466-9","article-title":"In vitro and in vivo efficacy of AZD3965 and Alpha-Cyano-4-Hydroxycinnamic acid in the murine 4T1 breast tumor model","volume":"22","author":"Guan","year":"2020","journal-title":"AAPS J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10555-016-9637-x","article-title":"PI3K\/AKT\/mTOR: role in breast cancer progression, drug resistance, and treatment","volume":"35","author":"Guerrero-Zotano","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","article-title":"Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of I\u03baB\u03b1","volume":"34","author":"Guo","year":"2022","journal-title":"Cell Metab."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1158\/0008-5472.CAN-20-2562","article-title":"Hypoxia-Driven oncometabolite L-2HG maintains stemness-differentiation balance and facilitates immune evasion in pancreatic cancer","volume":"81","author":"Gupta","year":"2021","journal-title":"Cancer Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3390\/biom14121646","article-title":"Lactate and lactylation: dual regulators of T-Cell-Mediated tumor immunity and immunotherapy","volume":"14","author":"Hao","year":"2024","journal-title":"Biomolecules"},{"key":"B44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41419-025-07431-4","article-title":"Glycolysis reprogramming in CAFs promotes oxaliplatin resistance in pancreatic cancer through circABCC4 mediated PKM2 nuclear translocation","volume":"16","author":"He","year":"2025","journal-title":"Cell Death Dis."},{"key":"B45","doi-asserted-by":"crossref","DOI":"10.21203\/rs.3.rs-4382720\/v1","volume-title":"A novel chemical entity, that reverses Warburg metabolism by disrupting VDAC1\/HK2 interaction through \u201cToposteric Effect\u201d in Cancer","author":"Herzberg","year":"2024"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1175563","DOI":"10.3389\/fonc.2023.1175563","article-title":"Association between pH regulation of the tumor microenvironment and immunological state","volume":"13","author":"Hosonuma","year":"2023","journal-title":"Front. Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcdb.2015.08.003","article-title":"MYC and metabolism on the path to cancer","volume":"43","author":"Hsieh","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jhep.2014.04.035","article-title":"CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway","volume":"61","author":"Huang","year":"2014","journal-title":"J. Hepatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"782065","DOI":"10.3389\/fonc.2021.782065","article-title":"LY294002 is a promising inhibitor to overcome sorafenib resistance in FLT3-ITD mutant AML cells by interfering with PI3K\/Akt signaling pathway","volume":"11","author":"Huang","year":"2021","journal-title":"Front. Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10585-011-9415-7","article-title":"Reduction of metastasis using a non-volatile buffer","volume":"28","author":"Ibrahim Hashim","year":"2011","journal-title":"Clin. Exp. Metastasis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tibs.2018.10.011","article-title":"Lactate: a metabolic driver in the tumour landscape","volume":"44","author":"Ippolito","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.7150\/ijbs.60018","article-title":"Crosstalk between hypoxia-sensing ULK1\/2 and YAP-driven glycolysis fuels pancreatic ductal adenocarcinoma development","volume":"17","author":"Jia","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"101311","DOI":"10.1016\/j.drup.2025.101311","article-title":"Microbiota in drug resistance","volume":"84","author":"Jia","year":"2026","journal-title":"Drug Resist Updat"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1492050","DOI":"10.3389\/fimmu.2024.1492050","article-title":"From metabolic byproduct to immune modulator: the role of lactate in tumor immune escape","volume":"15","author":"Jiang","year":"2024","journal-title":"Front. Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1007\/s13277-015-3070-6","article-title":"Involvement of acid-sensing ion channel 1\u03b1 in hepatic carcinoma cell migration and invasion","volume":"36","author":"Jin","year":"2015","journal-title":"Tumour Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3971\/j.issn.1000-8578.2020.20.0279","article-title":"Role of lactate dehydrogenase in tumor metabolism and progress of LDH-targeted drugs","volume":"47","author":"Jinmei","year":"2020","journal-title":"Zlfzyj"},{"key":"B57","doi-asserted-by":"publisher","first-page":"00146","DOI":"10.1016\/j.tem.2025.06.008","article-title":"Metabolic-immune microenvironment crosstalk mediating ICI resistance in MASH-HCC","author":"Ju","year":"2025","journal-title":"Trends Endocrinol. Metab."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.trecan.2022.08.001","article-title":"Mitochondrial DNA is a major source of driver mutations in cancer","volume":"8","author":"Kim","year":"2022","journal-title":"Trends Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e0174271","DOI":"10.1371\/journal.pone.0174271","article-title":"3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"B60","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s12951-023-02260-z","article-title":"Lonidamine liposomes to enhance photodynamic and photothermal therapy of hepatocellular carcinoma by inhibiting glycolysis","volume":"21","author":"Lei","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"110149","DOI":"10.1016\/j.abb.2024.110149","article-title":"STC2 knockdown inhibits cell proliferation and glycolysis in hepatocellular carcinoma through promoting autophagy by PI3K\/Akt\/mTOR pathway","volume":"761","author":"Li","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"B62","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.7150\/ijbs.115032","article-title":"BAY11-7082 targets RNF25 to reverse TRIP4 ubiquitination-dependent NF-\u03baB activation and apoptosis resistance in renal cell carcinoma","volume":"21","author":"Li","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1158\/1535-7163.MCT-12-0131","article-title":"A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo","volume":"11","author":"Liu","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"B64","doi-asserted-by":"publisher","first-page":"22055","DOI":"10.1021\/acs.jmedchem.5c02094","article-title":"Application of hypoxia-activated prodrugs in tumor therapy: design strategies and perspectives","volume":"68","author":"Liu","year":"2025","journal-title":"J. Med. Chem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11306-014-0672-8","article-title":"Metabolic consequences of LDHA inhibition by Epigallocatechin gallate and oxamate in MIA PaCa-2 pancreatic cancer cells","volume":"11","author":"Lu","year":"2015","journal-title":"Metabolomics"},{"key":"B66","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3390\/life11060505","article-title":"GLUT-1 enhances glycolysis, oxidative stress, and fibroblast proliferation in keloid","volume":"11","author":"Lu","year":"2021","journal-title":"Life (Basel)"},{"key":"B67","doi-asserted-by":"publisher","first-page":"21156","DOI":"10.1021\/acsnano.4c04024","article-title":"Mitochondria-Targeted multifunctional nanoprodrugs by inhibiting metabolic reprogramming for combating cisplatin-resistant lung cancer","volume":"18","author":"Lu","year":"2024","journal-title":"ACS Nano"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1200\/JCO.2008.18.8383","article-title":"[18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapy","volume":"27","author":"Ma","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s43018-023-00721-w","article-title":"Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma","volume":"5","author":"Mahmood","year":"2024","journal-title":"Nat. Cancer"},{"key":"B70","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-023-01820-z","article-title":"Expression of mTOR in normal and pathological conditions","volume":"22","author":"Marques-Ramos","year":"2023","journal-title":"Mol. Cancer"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e172656","DOI":"10.1172\/jci.insight.172656","article-title":"Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis","volume":"8","author":"Matte","year":"2023","journal-title":"JCI Insight"},{"key":"B72","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s42255-020-0195-8","article-title":"Identifying strategies to target the metabolic flexibility of tumours","volume":"2","author":"M\u00e9ndez-Lucas","year":"2020","journal-title":"Nat. Metab."},{"key":"B73","doi-asserted-by":"publisher","first-page":"116699","DOI":"10.1016\/j.ejmech.2024.116699","article-title":"Acid-sensitive prodrugs; a promising approach for site-specific and targeted drug release","volume":"276","author":"Nazli","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"58353","DOI":"10.18632\/oncotarget.16874","article-title":"Preventive effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic mice","volume":"8","author":"Obara","year":"2017","journal-title":"Oncotarget"},{"key":"B75","doi-asserted-by":"publisher","first-page":"106270","DOI":"10.1016\/j.phrs.2022.106270","article-title":"Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells","volume":"181","author":"Pan","year":"2022","journal-title":"Pharmacol. Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","article-title":"Monocarboxylate transporters in cancer","volume":"33","author":"Payen","year":"2020","journal-title":"Mol. Metab."},{"key":"B77","doi-asserted-by":"publisher","first-page":"189164","DOI":"10.1016\/j.bbcan.2024.189164","article-title":"Lactic acid: the culprit behind the immunosuppressive microenvironment in hepatocellular carcinoma","volume":"1879","author":"Peng","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1515\/hsz-2018-0411","article-title":"MCT1, MCT4 and CD147 expression and 3-bromopyruvate toxicity in colorectal cancer cells are modulated by the extracellular conditions","volume":"400","author":"Pereira-Vieira","year":"2019","journal-title":"Biol. Chem."},{"key":"B79","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.3390\/ijms20174131","article-title":"Hepatic Tumor microenvironments and effects on NK cell phenotype and function","volume":"20","author":"Pi\u00f1eiro Fern\u00e1ndez","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.3390\/curroncol30070485","article-title":"Anti-Glycolytic drugs in the treatment of hepatocellular carcinoma: systemic and locoregional options","volume":"30","author":"Pourbaghi","year":"2023","journal-title":"Curr. Oncol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/abbs\/gmz105","article-title":"Propofol attenuates the adhesion of tumor and endothelial cells through inhibiting glycolysis in human umbilical vein endothelial cells","volume":"51","author":"Qi","year":"2019","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"B82","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s13046-021-02191-3","article-title":"The IRF2\/CENP-N\/AKT signaling axis promotes proliferation, cell cycling and apoptosis resistance in nasopharyngeal carcinoma cells by increasing aerobic glycolysis","volume":"40","author":"Qi","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"e1511","DOI":"10.1002\/ctm2.1511","article-title":"RFX6 facilitates aerobic glycolysis-mediated growth and metastasis of hepatocellular carcinoma through targeting PGAM1","volume":"13","author":"Qiu","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3390\/cells13070638","article-title":"Nanoquercetin and extracellular vesicles as potential anticancer therapeutics in hepatocellular carcinoma","volume":"13","author":"Raghav","year":"2024","journal-title":"Cells"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3390\/cells13221924","article-title":"Emerging role of extracellular pH in tumor microenvironment as a therapeutic target for cancer immunotherapy","volume":"13","author":"Rahman","year":"2024","journal-title":"Cells"},{"key":"B86","doi-asserted-by":"publisher","first-page":"101154","DOI":"10.1016\/j.redox.2019.101154","article-title":"Critical role of AMPK in redox regulation under glucose starvation","volume":"25","author":"Ren","year":"2019","journal-title":"Redox Biol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejca.2017.10.010","article-title":"Liver immunotolerance and hepatocellular carcinoma: Patho-physiological mechanisms and therapeutic perspectives","volume":"87","author":"Roth","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"B88","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jcmgh.2020.10.010","article-title":"Nanoparticle-Mediated delivery of 2-Deoxy-D-Glucose induces antitumor immunity and cytotoxicity in liver tumors in mice","volume":"11","author":"Sasaki","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/bjc.2012.559","article-title":"Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma","volume":"108","author":"Shen","year":"2013","journal-title":"Br. J. Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"150709","DOI":"10.1016\/j.bbrc.2024.150709","article-title":"Knockdown of SLC16A3 decreases extracellular lactate concentration in hepatocellular carcinoma, alleviates hypoxia and induces ferroptosis","volume":"733","author":"Shen","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B91","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s42452-025-08114-7","article-title":"L lactate dehydrogenase drives cancer metabolism and offers new therapeutic opportunities","volume":"8","author":"Taha","year":"2026","journal-title":"Discov. Appl. Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/HEP.0000000000000390","article-title":"Ferroptosis in hepatocellular carcinoma: from bench to bedside","volume":"80","author":"Tang","year":"2023","journal-title":"Hepatology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1038\/s41388-022-02391-x","article-title":"PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma","volume":"41","author":"Thirusangu","year":"2022","journal-title":"Oncogene"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1016\/j.cmet.2024.10.019","article-title":"Dual impacts of serine\/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation","volume":"36","author":"Tong","year":"2024","journal-title":"Cell Metab."},{"key":"B95","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol. Cancer"},{"key":"B96","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.1093\/nar\/gkz619","article-title":"The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112","volume":"47","author":"van Tran","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.3892\/mmr.2014.2945","article-title":"Glycolysis inhibitor 2-deoxy-D-glucose suppresses carcinogen-induced rat hepatocarcinogenesis by restricting cancer cell metabolism","volume":"11","author":"Wang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"B98","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.3390\/ijms21218363","article-title":"Lactic acid and an acidic tumor microenvironment suppress anticancer immunity","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/mc.70067","article-title":"Linarin suppresses the progression of colorectal cancer by inhibiting the HIF-1\u03b1\/PD-L1 axis","volume":"65","author":"Wang","year":"","journal-title":"Mol. Carcinog."},{"key":"B100","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.tem.2024.08.009","article-title":"Metabolic reprogramming of macrophages in cancer therapy","volume":"36","author":"Wang","year":"","journal-title":"Trends Endocrinol. Metab."},{"key":"B101","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"B102","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1021\/acs.jafc.0c07640","article-title":"Kaempferol reverses aerobic glycolysis via miR-339-5p-Mediated PKM alternative splicing in Colon cancer cells","volume":"69","author":"Wu","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"B103","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/cac2.12403","article-title":"METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression","volume":"43","author":"Xia","year":"2023","journal-title":"Cancer Commun. (Lond)"},{"key":"B104","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cmet.2014.03.003","article-title":"Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells","volume":"19","author":"Xie","year":"2014","journal-title":"Cell Metab."},{"key":"B105","doi-asserted-by":"publisher","first-page":"8923","DOI":"10.7314\/apjcp.2014.15.20.8923","article-title":"High monocarboxylate transporter 4 protein expression in stromal cells predicts adverse survival in gastric cancer","volume":"15","author":"Yan","year":"2014","journal-title":"Asian Pac J. Cancer Prev."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1097\/HEP.0000000000000005","article-title":"Metabolic reprogramming and its clinical implication for liver cancer","volume":"78","author":"Yang","year":"","journal-title":"Hepatology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s42255-022-00710-w","article-title":"Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma","volume":"5","author":"Yang","year":"","journal-title":"Nat. Metab."},{"key":"B108","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.7150\/jca.27279","article-title":"Oncogenic virus-induced aerobic glycolysis and tumorigenesis","volume":"9","author":"Yu","year":"2018","journal-title":"J. Cancer"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2147\/OTT.S233031","article-title":"Knockdown of FOXO6 inhibits glycolysis and reduces cell resistance to Paclitaxel in HCC cells via PI3K\/Akt signaling pathway","volume":"13","author":"Yu","year":"2020","journal-title":"Onco Targets Ther."},{"key":"B110","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1111\/jcmm.17322","article-title":"Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc\/hexokinase 2 pathway","volume":"26","author":"Yu","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1080\/21655979.2021.1951928","article-title":"Comprehensive Analysis of Monocarboxylate Transporter 4 (MCT4) expression in breast cancer prognosis and immune infiltration via integrated bioinformatics analysis","volume":"12","author":"Yuan","year":"2021","journal-title":"Bioengineered"},{"key":"B112","doi-asserted-by":"publisher","first-page":"15947","DOI":"10.1074\/jbc.RA118.004180","article-title":"Double genetic disruption of lactate dehydrogenases A and B is required to ablate the \u201cWarburg effect\u201d restricting tumor growth to oxidative metabolism","volume":"293","author":"\u017ddralevi\u0107","year":"2018","journal-title":"J. Biol. Chem."},{"key":"B113","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/jcb.22984","article-title":"Silybin and dehydrosilybin decrease glucose uptake by inhibiting GLUT proteins","volume":"112","author":"Zhan","year":"2011","journal-title":"J. Cell Biochem."},{"key":"B114","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.biopha.2015.05.019","article-title":"Inhibition of c-Myc by 10058-F4 induces growth arrest and chemosensitivity in pancreatic ductal adenocarcinoma","volume":"73","author":"Zhang","year":"","journal-title":"Biomed. Pharmacother."},{"key":"B115","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.12659\/msm.895034","article-title":"2-DG-Regulated RIP and c-FLIP effect on liver cancer cell apoptosis induced by TRAIL","volume":"21","author":"Zhang","year":"","journal-title":"Med. Sci. Monit."},{"key":"B116","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"B117","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.7150\/thno.72581","article-title":"mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"B118","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-024-02009-8","article-title":"ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment","volume":"23","author":"Zhang","year":"","journal-title":"Mol. Cancer"},{"key":"B119","doi-asserted-by":"publisher","first-page":"117572","DOI":"10.1016\/j.jep.2023.117572","article-title":"Exploring the molecular mechanism of Artemisia rupestris L. for the treatment of hepatocellular carcinoma via PI3K\/AKT pathway","volume":"322","author":"Zhang","year":"","journal-title":"J. Ethnopharmacol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"123832","DOI":"10.1016\/j.biomaterials.2025.123832","article-title":"Glycolysis-inhibiting tumor cell-derived microparticles to enhance immunogenic cell death for synergistic cancer immunotherapy","volume":"328","author":"Zhang","year":"2026","journal-title":"Biomaterials"},{"key":"B121","doi-asserted-by":"publisher","first-page":"175226","DOI":"10.1016\/j.ejphar.2022.175226","article-title":"Kaempferol impairs aerobic glycolysis against melanoma metastasis via inhibiting the mitochondrial binding of HK2 and VDAC1","volume":"931","author":"Zheng","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"102458","DOI":"10.1016\/j.redox.2022.102458","article-title":"GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism","volume":"56","author":"Zhou","year":"2022","journal-title":"Redox Biol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000530495","article-title":"Guidelines for the diagnosis and treatment of primary liver cancer (2022 edition)","volume":"12","author":"Zhou","year":"2023","journal-title":"Liver Cancer"},{"key":"B124","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/microorganisms14010073","article-title":"The dual role of Gut Microbiota and their metabolites in hepatocellular carcinoma: a context-dependent framework","volume":"14","author":"Zuo","year":"2025","journal-title":"Microorganisms"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1704729\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:42:57Z","timestamp":1778215377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1704729\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":124,"alternative-id":["10.3389\/fphar.2026.1704729"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1704729","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"article-number":"1704729"}}